New research has shown that fewer than one in 1,000 US adolescents with commercial insurance receives gender-affirming medication, and none at all aged under 12, despite increasingly hysterical right wing claims to the contrary.
Published in Jama Pediatrics on Monday (6 January), the figures revealed just how few adolescents with commercial insurance received gender-affirming medication, including puberty blockers and hormones, during a five-year period.
The researchers analysed an insurance claims database that covered more than five million patients aged eight to 17 across all 50 states. And they discovered that only 926 adolescents with a gender-related diagnosis received puberty blockers between 2018 and 2022.
The figures didn’t include youngsters covered by Medicaid, the federal health insurance programme for people on low incomes.
During that same period, 1,927 of them received hormones, suggesting that not even 0.1 per cent of all youth in the database received the medicine.
The researchers also found that no patients under the age of 12 were prescribed gender-affirming medication.
In September 2024, at a campaign rally in Wisconsin, Trump repeated false claims that children are undergoing transgender surgery during the school day. “Can you imagine you’re a parent and your son leaves the house and you say, ‘Jimmy, I love you so much, go have a good day in school,’ and your son comes back with a brutal...
Lakshmi Bethi DMD, her businesses New Haven Dental, New Haven Family Dental, New Haven Family Dental Group settle federal case for $608,296. Ellyn Santiago, Patch Staff NEW HAVEN, CT — Tuesday, a N...